Microsoft Corp (MSFT) 54.31 $MSFT Arjuna: Microsoft Is

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Microsoft Corp (MSFT) 54.31 $MSFT

Arjuna: Microsoft Is Fifth Tech Giant This Year To Respond To Shareholder Push For Gender Pay Equity
PR Newswire - Mon Apr 11, 2:08PM CDT
On the eve of Equal Pay Day, Microsoft (NASDAQ: MSFT) is now the fifth major U.S. tech company this year to respond to shareholder calls for action on closing the gender pay equity gap. At the conclusion of a successful shareholder dialogue, Arjuna Capital, a division of Baldwin Brothers Inc., a registered investment advisor, withdrew their shareholder resolution that otherwise would have put the matter to a vote of Microsoft shareholders in December.
MSFT: 54.31 (-0.11)

Why Vonage Holdings, 8x8, and RingCentral Plunged in March
Anders Bylund, The Motley Fool - Motley Fool - Mon Apr 11, 11:23AM CDT
Image source: Pexels . What: The stock of three Voice over Internet Protocol providers fell last month. Shares of Vonage Holdings fell 14.9% in March, according to data from S&P Global Market Intelligence . By the end of the month, the...
RNG: 16.09 (-0.74), MSFT: 54.31 (-0.11), VG: 4.58 (+0.06), EGHT: 10.54 (+0.12)

Why Red Hat, Inc. Gained 14% in March
Anders Bylund, The Motley Fool - Motley Fool - Mon Apr 11, 10:55AM CDT
Image source: Red Hat. What: Shares of Red Hat rose 14% in March, according to data from S&P Global Market Intelligence . So what: There was no single shot of brilliance behind this month-long move, but more of a slow climb to the...
RHT: 72.84 (-0.96), MSFT: 54.31 (-0.11)

Daily Mail Joins the List of Could-Be Yahoo! Suitors
at The Street - Mon Apr 11, 8:54AM CDT
The U.K.'s Daily Mail throws its hat into the ring of potential bidders for Yahoo!.
TIME: 14.60 (+0.03), YHOO: 36.48 (+0.41), MSFT: 54.31 (-0.11), IAC: 46.55 (-0.29), VZ: 51.61 (-0.57), CBS: 53.52 (-0.60)

Global Mixed Reality Market Report 2016-2021 - Analysis, Technologies & Forecasts - Key Vendors: Seiko Epson Corp, Microsoft Corp, Meta Company - Research and Markets
BusinessWire - Mon Apr 11, 7:42AM CDT
Research and Markets has announced the addition of the "Mixed Reality Market- By Technology (Hardware, Software & Algorithms); By Display Devices (HUD, HMD, Others); By Application (Tourism, Military, Others); By End User Industries (Automotive, Aerospace, Medical, Others)-Forecast to 2021" report to their offering.
MSFT: 54.31 (-0.11)

Microsoft Corporation Might Launch 3 New Windows 10 Phones
Leo Sun, The Motley Fool - Motley Fool - Sun Apr 10, 3:14PM CDT
Microsoft could release three new Windows 10 Mobile smartphones in 2017, according to a recent report at Windows Central . The first model will target mainstream consumers, the second one will target higher-end "prosumers,"...
MSFT: 54.31 (-0.11), AAPL: 109.02 (+0.36)

Tweets on the Street: Gates on Poverty, Pimco on China and Citi Goes Yard
at The Street - Fri Apr 08, 3:45PM CDT
Wall Street social-media chatter Friday ranged from macroeconomic threats to MLB home-run charitable pledges.
C: 41.12 (+0.65), MSFT: 54.31 (-0.11)

Microsoft announces quarterly earnings release date
PR Newswire - Fri Apr 08, 11:00AM CDT
Microsoft Corp. will publish fiscal year 2016 third-quarter financial results after the close of the market on Thursday, April 21, 2016, on the Microsoft Investor Relations website at https://www.microsoft.com/en-us/Investor/. A live webcast of the earnings conference call will be made available at 2:30 p.m. PDT.
MSFT: 54.31 (-0.11)

Next Resistance Level for Microsoft (MSFT) is $55.21
Comtex SmarTrend(R) - Fri Apr 08, 9:23AM CDT
Microsoft (NASDAQ:MSFT) has opened bullishly above the pivot of $54.53 today and has reached the first level of resistance at $54.84. Should the shares continue to rise, the resistance pivots of $55.21 and $55.89 will be of interest.
MSFT: 54.31 (-0.11)

Dow 30 Stock Roundup: Boeing Wins $510M Contracts, GE Sheds Key Units
Swarup Gupta - Zacks Investment Research - Fri Apr 08, 8:25AM CDT
The Dow moved lower this week due to heightened concerns about global growth and declining oil prices.
AGN: 228.37 (-7.63), JNJ: 108.97 (-0.13), GE: 30.71 (-0.08), IBM: 149.25 (-0.10), PFE: 31.89 (-0.61), WMT: 67.40 (-0.66), TM: 98.43 (-2.23), MSFT: 54.31 (-0.11), BA: 127.91 (+0.03), CRM: 74.16 (-0.69)

Verizon & Google Lining Up Yahoo Bids
Ryan McQueeney - Zacks Investment Research - Thu Apr 07, 4:54PM CDT
Despite the financial perils of Yahoo (YHOO) becoming more and more apparent, it looks like we will indeed see some takeover bids in the coming weeks. After the company issued a deadline for bids last week, reports now indicate that both Verizon (VZ) and Google (GOOGL) are considering offers.
TIME: 14.60 (+0.03), T: 38.39 (-0.11), YHOO: 36.48 (+0.41), GOOGL: 757.54 (-1.93), MSFT: 54.31 (-0.11), CMCSA: 61.44 (-0.16), VZ: 51.61 (-0.57)

Why a Stock's P/E Always Matters
at The Street - Thu Apr 07, 2:00PM CDT
Both growth and value investors must pay attention to valuations.
KO: 46.44 (-0.43), IBM: 149.25 (-0.10), XOM: 83.32 (+0.11), WMT: 67.40 (-0.66), MSFT: 54.31 (-0.11)

Why the 'Hybrid Cloud' Is So Important to IBM's Future
at The Street - Thu Apr 07, 12:20PM CDT
The tech giant's focus on selling customers a mix of public and private clouds -- a market it pegs at $100 billion -- is critical to its turnaround plans.
ANTM: 140.90 (-2.84), AMZN: 595.93 (+1.33), IBM: 149.25 (-0.10), GOOGL: 757.54 (-1.93), MSFT: 54.31 (-0.11), CRM: 74.16 (-0.69)

Everything You Wanted to Know About the Cloud But Were Afraid to Ask
at The Street - Thu Apr 07, 12:18PM CDT
Analyst Kim Forrest, a former software engineer, explains why every company wants to get into the cloud now and who's winning the battle to provide services.
AMZN: 595.93 (+1.33), IBM: 149.25 (-0.10), GOOGL: 757.54 (-1.93), MSFT: 54.31 (-0.11), GOOG: 736.10 (-3.05)

Can Amazon Continue to Dominate the Cloud Industry It Created?
at The Street - Thu Apr 07, 12:17PM CDT
Amazon still holds a formidable lead in enabling companies to store their data remotely, but Google, Microsoft and IBM are fast on its heels.
AMZN: 595.93 (+1.33), IBM: 149.25 (-0.10), GOOGL: 757.54 (-1.93), MSFT: 54.31 (-0.11), AAPL: 109.02 (+0.36), GOOG: 736.10 (-3.05)

Auto Stock Roundup: Tesla Launches Model 3, U.S. Auto Sales Up in March, Toyota & Microsoft Team Up
Zacks Equity Research - Zacks Investment Research - Thu Apr 07, 10:12AM CDT
Tesla (TSLA) launched Model 3, which pulled up the stock by 17%. U.S. light-vehicle sales for March improved 3.1%. Toyota (TM) teamed up with Microsoft (MSFT).
TSLA: 249.92 (-0.15), F: 12.66 (+0.11), AAP: 154.77 (-1.34), TM: 98.43 (-2.23), MSFT: 54.31 (-0.11), HMC: 26.14 (-0.26)

5 Big Stocks to Trade After the Fed's Comments
at The Street - Thu Apr 07, 5:37AM CDT
Here's a technical look at how to trade some of the biggest stocks on Wall Street.
SLM: 6.25 (+0.09), COTY: 28.49 (-0.46), AZN: 29.09 (-0.36), PG: 82.73 (-0.47), MSFT: 54.31 (-0.11)

Microsoft's Price Target Hiked by Cowen; Rating Retained
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 12:25PM CDT
Microsoft Corporation's (MSFT) price target was recently raised by more than 3% to $59 from $57 by investment firm, Cowen. In addition, analysts retained the stock's rating of Market Perform.
BLKB: 61.67 (-0.71), NTWK: 6.97 (+0.06), MSFT: 54.31 (-0.11)

The Zacks Analyst Blog Highlights: eBay, Amazon, Microsoft, IBM and Alphabet
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 8:30AM CDT
The Zacks Analyst Blog Highlights: eBay, Amazon, Microsoft, IBM and Alphabet
AMZN: 595.93 (+1.33), EBAY: 24.06 (-0.01), IBM: 149.25 (-0.10), GOOGL: 757.54 (-1.93), MSFT: 54.31 (-0.11)

PLEXIS Healthcare Systems Achieves a Microsoft Gold Application Development Competency
PR Newswire - Wed Apr 06, 7:00AM CDT
PLEXIS Healthcare Systems, today announced it has achieved a Gold Application Development competency, demonstrating a "best-in-class" ability and commitment to meet Microsoft Corp. customers' evolving needs in today's dynamic business environment and distinguishing itself within the top 1 percent of Microsoft's partner ecosystem.
MSFT: 54.31 (-0.11)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sarepta Under Scrutiny: KSF's Investigation Deepens

Updated Category News Views 3

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Continue Reading
Cyngn: A Deep Dive into Its Robust 24-Patent Portfolio

Updated Category News Views 4

Cyngn's Growing Patent Portfolio: A Robust Defense Ah, Cyngn Inc., the hotshot in AI-powered autonomous vehicle tech, is flexing its muscles with a solid 24-patent stash. We're talking about a company that's not messing around, racking these up since they decided to dive head-first into solving the brain-busting problems of the industrial sector. Their strategy? Build and...

Continue Reading
New Concierge Pediatric Care at Weill Cornell Launches

Updated Category News Views 3

A New Way Forward in Pediatric Care When a couple of seasoned pediatricians decide it's time for something fresh, eyes and ears perk up. Enter Dr. Paul W. Chung and Dr. Jane E. Rosini, diving headfirst into a revolutionary pediatric concierge program courtesy of Concierge Choice Physicians (CCP). We're talking a substantial shake-up at Weill Cornell Medicine, aiming to...

Continue Reading
Postal Service Defends New Rule Amid Speculation

Updated Category News Views 3

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Continue Reading
Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Updated Category News Views 6

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

Continue Reading
BellRing Brands Faces Legal Probe; Fiduciary Duties Questioned

Updated Category News Views 1

What's Stirring at BellRing Brands? Hey, no time like the present to dive headfirst into this mess BellRing's found itself in. On the heels of a lackluster sales forecast, just announced about a year ago, Kahn Swick & Foti's got their magnifying glasses out, searching for any shady dealings by those running the show at BellRing Brands, LLC. Why Is BellRing in the Hot...

Continue Reading
S&P 500 Shuffle: Bloom, Illumina, Everpure Join Frenzy

Updated Category News Views 5

Index Shuffles Stir Market Pot Changes are afoot, folks, with the movers and shakers of the market indices stepping into the spotlight. A lot is brewing with S&P Dow Jones Indices making significant switches effective September 21, 2026—right before trading heats up. You better believe it's affecting more than a couple of tickers. Who's In and Who's Out? If you’ve...

Continue Reading
TrailBlazer Magazine Snags a Tribune for In-House Design

Updated Category News Views 4

Who Knew? Design Awards Aren't Just for Pretty Pictures TrailBlazer Magazine gets a pat on the back from GDUSA's 2026 Inhouse Design Awards, a nod to top-notch design work. With over 4,000 entries across the board, getting into the top 10 percent is like finding a steakhouse with zero line on a Friday night. Not exactly common, right? Design Worth Cheering For The winning...

Continue Reading
MMRO Achieves URAC AI Accreditation, Ensures Compliance

Updated Category News Views 4

A Milestone in Healthcare AI: MMRO's New Accreditation When AI in healthcare gets an official nod from the big guys like URAC, it's a significant moment. We're talking about Managed Medical Review Organization, Inc. (MMRO), a firm that's just earned the URAC Artificial Intelligence in Health Care Accreditation. Now, this isn't just some rubber stamp; it's a testament to...

Continue Reading
Dimerix Locks Down A$34M Loan: No Shareholder Dilution

Updated Category News Views 2

Dimerix Grabs Non-Dilutive Funds amid Kidney Trials Here we go with Dimerix's latest move, folks. They roped in A$34 million through a cozy get-together with lenders from Australia and the U.S. What's the kicker? This cash won't touch shareholder equity. So, breathe easy, investors. It's a rare feat to pull off non-dilutive funds these days, especially in the biopharma...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming the Narcolepsy Market: Innovations Ahead

Updated Category News Views 166

The Evolving Landscape of the Narcolepsy Market The narcolepsy market is undergoing significant changes as it shifts from merely managing symptoms to developing targeted therapies that tackle the root causes of the disorder. Traditionally, treatments focused on alleviating symptoms, but advancements now emphasize addressing the underlying neurochemical issues, primarily...

Continue Reading
UBS Analysts Share Insights on China Stocks Strategies

Updated Category News Views 242

UBS Analysts Offer Insights on China's Equity Market In a recent discussion, UBS strategists have expressed a level of caution regarding China's equity market as they look into the evolving landscape of 2025. It's noted that local A-share investors appear hesitant to seize buying opportunities, influenced by a myriad of factors that create uncertainty in the market....

Continue Reading
Palisade Bio's Special Meeting Cancellation: What You Need to Know

Updated Category News Views 133

Palisade Bio Cancels Special Meeting of Stockholders Palisade Bio, Inc. (Nasdaq: PALI) is a clinical-stage biopharmaceutical company making strides in developing innovative treatments for autoimmune, inflammatory, and fibrotic diseases. Recently, the company announced an important decision regarding its special meeting of stockholders. The special meeting, originally...

Continue Reading
Vivendi Reports Impressive 4.5% Revenue Growth in 2024

Updated Category News Views 123

Remarkable Revenue Growth for Vivendi Vivendi has announced an impressive increase in its revenues for the first nine months of 2024, emphasizing strong growth across its core business sectors. The company reported a revenue increase of 4.5% at constant currency and perimeter, compared to the same period in the previous year. This growth showcases the resilience and...

Continue Reading
Revolution in Home Renovation Arrives with Spray-Net Franchise

Updated Category News Views 226

Fresh Approach to Home Makeovers Home remodeling isn’t just about slapping on a new coat of paint anymore. In February 2026, Spray-Net is gearing up to launch in Allen, Texas, shaking things up in the renovation game. This venture represents a leap forward—not only for franchise growth but for homeowners who are sick and tired of traditional, drawn-out renovations....

Continue Reading